The mechanistic insights gathered from clinical studies of patients, as well as the application of Wnt5a intervenor, hold significant clinical implications for the development of therapeutic approaches aimed at preventing and treating various mesenchymal transition and repair dysregulation diseases, including asthma. This evidence concerns the gene WNT5A and asthma.